Taking part in Crohn's research

How to find a study, what happens in a trial, the questions to ask, and your rights if you take part

5 min read Updated 16 November 2026 11 sources

In short

  • Ask your IBD team whether your hospital is running any studies. You can also search the NIHR's free Be Part of Research service.
  • The IBD BioResource invites people with Crohn's or colitis to give a blood sample and agree to be contacted about future studies.
  • In most trials you are put into a group by chance and may get the new treatment, a standard treatment or a placebo.
  • Every study involving people in the UK must be approved by an independent research ethics committee.
  • You can leave a trial at any time without giving a reason, and it will not affect your usual care.
  • You can also help by shaping research, for example through Crohn's & Colitis UK's patient involvement and Research Champions.
On this page
  1. Why take part in research?
  2. What kinds of research can I join?
  3. How do I find a study?
  4. What happens in a clinical trial?
  5. What should I ask before I agree?
  6. Is it safe, and can I change my mind?
  7. Sources

Why take part in research?

The NHS says clinical trials help doctors understand how best to treat an illness, and taking part may help you or other people like you in the future. If you join a trial of a new treatment, you may be one of the first to benefit. But the NHS is also clear that the new treatment may turn out to be no better, or even worse, than the standard one.1

Much of what is known about Crohn's treatment today comes from people who took part in trials. The UK PROFILE trial, for example, involved 386 newly diagnosed people aged 16 to 80 across 40 UK hospitals, and its researchers concluded that strong 'top-down' treatment should be considered standard care for newly diagnosed active Crohn's.23

Crohn's & Colitis UK says research works best when it includes a diverse range of people, so the results meet the needs of everyone, whatever their ethnicity, age, disability, gender or background.4

What kinds of research can I join?

Research is not only drug trials. The NHS says studies can test vaccines, scans and blood tests, medicines, and ways to control symptoms or improve quality of life, such as diets. For Crohn's, the main options include:1

  • Clinical trials of medicines or other treatments, run at hospitals around the UK.
  • The NIHR IBD BioResource: a national panel of people with Crohn's or colitis who give a blood sample, answer questions about their health and how they live, and say they are happy to be asked about later studies. It runs in more than 80 UK hospitals, has a children's arm, and is currently especially keen to recruit Black and Asian adults and people diagnosed in the past 12 months.
  • The National IBD Registry: collects information about people's diagnosis, treatment and care from hospital teams and from patients, to improve care and support research. It works with more than 100 UK hospitals and became part of NHS England in 2026.
  • Helping shape research: Crohn's & Colitis UK runs patient and public involvement, where people with Crohn's help design and guide studies, and a Research Champions scheme.1456

Crohn's & Colitis UK has funded research since 1979, awarding more than £13 million in grants, and publishes the projects it funds. Guts UK's Crohn's page describes a James Lind Alliance priority-setting partnership, in which people with Crohn's, their carers and researchers agreed a top 10 list of questions they want answered.78

How do I find a study?

The NHS suggests starting by asking your doctor, or a patient organisation, whether there are any trials you might be able to join. For Crohn's, your IBD team is the best first contact. To join the IBD BioResource you need to go through a hospital clinic, so check whether your hospital is taking part.15

You can also search yourself:1

  • Be Part of Research: a free NIHR service covering England, Scotland, Wales and Northern Ireland. You can search for studies, or tell it which conditions interest you and get matched to suitable studies.
  • ISRCTN registry: a study registry recognised by the World Health Organization that aims to include all UK clinical studies, ideally recorded before they start.
  • ClinicalTrials.gov: a large worldwide database run by the US government, which includes many trials taking place at UK hospitals.
  • The WHO International Clinical Trials Registry Platform, which the NHS lists for trials worldwide.191011

What happens in a clinical trial?

New medicines go through a series of phases. The NHS explains that early phases test safety and the right dose in small groups. Later phases test the medicine in larger groups of patients against an existing treatment or a placebo (dummy treatment), often for a year or more. Safety is still watched after a medicine is licensed.1

In most trials, a computer decides at random whether you are in the treatment group or the control group, which gets a standard treatment or a placebo. Many trials are 'blinded', so you and sometimes your doctors do not know which group you are in. The NHS says this helps make the comparison fair.1

Taking part can mean extra visits, tests and monitoring compared with usual care. Some trials pay participants, while others only cover travel costs.1

What should I ask before I agree?

Before you sign up, a doctor or nurse will usually explain the study and give you written information to take away. The NHS suggests questions to ask, including:1

  • What is the trial for, and how might it help people?
  • What treatment would I get if I did not take part?
  • How long will it last, and how much of my time will it take? Will I need time off work?
  • Will my travel costs be paid?
  • What side effects might I have, and how could the treatment affect me physically and emotionally?
  • What happens if I stop the treatment or leave early?
  • Who do I contact if I have a problem, and is someone available 24 hours a day?
  • How and when will I find out the results?1

The NHS also says to weigh up the downsides: trials can be time-consuming, may involve restrictions such as not eating or drinking alcohol for a time, and may cause side effects that were not known about.1

Is it safe, and can I change my mind?

The NHS explains that trials of new medicines must be authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). All medical research involving people in the UK must first be approved by an independent research ethics committee, overseen by the Health Research Authority, to protect participants' rights and interests. The NHS says it is rare for people to be harmed by trial treatments, but you can ask about compensation.1

You can leave a trial at any time, without giving a reason, and it will not affect the care you receive. You may also decide to stop if your condition is getting worse or the treatment is not helping.1

For studies that store samples or data, such as the IBD BioResource, participants agree to long-term secure storage. The BioResource says data shared with approved researchers is de-identified, so people cannot be identified from it.5

At the end of a trial, the NHS says researchers should publish their findings and share them with any participants who want them. If you are not offered the results, you can ask.1

Sources

This article is written in our own words from these sources. Each number in the text points to one of them.

  1. NHS Clinical trials Web page, Dec 2022 Read on the NHS website: Clinical trials
  2. The Lancet Gastroenterology & Hepatology A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE) Study, May 2024 Read the paper: A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE)
  3. The Lancet Gastroenterology & Hepatology Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial Study, Nov 2026 Read the paper: Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
  4. Crohn's & Colitis UK Want to get involved in research? Read on the Crohn's & Colitis UK website: Want to get involved in research?
  5. NIHR BioResource IBD BioResource Read on the NIHR BioResource website: IBD BioResource
  6. National IBD Registry National IBD Registry Read on the National IBD Registry website: National IBD Registry
  7. Crohn's & Colitis UK About our Research Read on the Crohn's & Colitis UK website: About our Research
  8. Guts UK Crohn's Disease Web page, Mar 2026 Read on the Guts UK website: Crohn's Disease
  9. NIHR Be Part of Research Read on the NIHR website: Be Part of Research
  10. ISRCTN ISRCTN Registry Read on the ISRCTN website: ISRCTN Registry
  11. US National Library of Medicine ClinicalTrials.gov Read on the US National Library of Medicine website: ClinicalTrials.gov